It is not a replacement for resistance training and adequate protein intake , but it adds another layer of protection for your muscle tissue during a period when it is particularly vulnerable
Terzepatide, another GLP-1 but also with GIP activation, is also being used by many young women desiring weight loss. Given the uncertainties, Hynes suggested, There is also the option of telling them not to take it, as there could be potential risks in childbearing ages. Yet she also acknowledges that as more women experience weight loss with these medications, unintended pregnancies may occur
Basal-bolus: Long-acting plus a rapid-acting insulin with each meal: the gold standard for type 1 diabetes
I do, he said
By recognizing and reporting this side effect, patients can work with their healthcare providers to find ways to manage it and continue their treatment effectively
The medication has demonstrated significant weight loss in clinical trials, with participants losing an average of 12-15% of their body weight over 68 weeks in the STEP clinical trial programme
